Understanding drug-related side effects in breast cancer treatment
Analyzing Patient-Level Data in a Breast Cancer Clinical Trial
This study is looking at how women being treated for breast cancer experience side effects, like tiredness and nerve pain, to help improve communication with their doctors and find ways to make those side effects easier to manage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10890574 on NIH RePORTER |
What this research studies
This research focuses on analyzing patient-level data from a clinical trial to better understand the side effects experienced by women undergoing treatment for breast cancer. By utilizing an electronic patient-reported outcomes platform, the study aims to collect and assess information on adverse events and quality of life in real time. This approach seeks to improve the recognition of drug-related toxicities, such as fatigue and neuropathy, which are often underreported. The goal is to enhance communication between patients and healthcare providers, leading to timely interventions that can mitigate serious side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with high-risk, early-stage breast cancer who are undergoing treatment.
Not a fit: Patients who are not currently receiving treatment for breast cancer or those with late-stage breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management of side effects in breast cancer treatments, enhancing patients' quality of life.
How similar studies have performed: Other research has shown that patient-reported outcomes can significantly improve the management of treatment side effects, indicating a promising approach in this area.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Somani, Amrita Basu — University of California, San Francisco
- Study coordinator: Somani, Amrita Basu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.